4-Aminopyrazolopyrimidine scaffold and its deformation in the design of tyrosine and serine/threonine kinase inhibitors in medicinal chemistry
- RSC Med Chem. 2022 Jul 15;13(9):1008-1028. doi: 10.1039/d2md00139j.
- 1. Department of Pharmacy, Jingzhou Hospital Affiliated to Yangtze University Jingzhou Hubei 434020 China [email protected].
- 2. Affiliated Xiaoshan Hospital, Hangzhou Normal University Hangzhou 311202 Zhejiang P. R. China.
- 3. School of Pharmaceutical Sciences, Wenzhou Medical University Wenzhou Zhejiang 325035 China [email protected].
The 4-Aminopyrazolopyrimidine scaffold has been an interesting pharmacophore since the disclosure of the intimate connection between small-molecule inhibitors and the treatment of diseases. Modification of the 4-aminopyrazolopyrimidine scaffold according to different targets, especially tyrosine kinase and serine/threonine kinase, has resulted in a variety of small-molecule inhibitors. Kinase inhibitors with 4-aminopyrazolopyrimidine derivatives as scaffolds have been widely applied in the treatment of diseases. In this article, we summarized the reports on 4-aminopyrazolopyrimidine as well as its deformation and the application of its derivatives in designing small-molecule inhibitors and the treatment of diseases.